Shares of Protalix BioTherapeutics (AMEX:PLX) were gapping down Tuesday morning with an open price % lower than Monday's closing price. The stock closed at. Protalix BioTherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PLX updated stock price target summary. Find the latest Protalix Biotherapeutics Inc (PLX) stock forecast, month price target, predictions and analyst recommendations. Earnings for Protalix BioTherapeutics are expected to grow by % in the coming year, from $ to $ per share. Price to Earnings Ratio vs. the Market. Based on 7 Wall Street analysts offering 12 month price targets for PLUXEE N.V. in the last 3 months. The average price target is € with a high forecast of.
Performance History Market Value Patterns Correlation Forecast · PLX Stock, USD %. Protalix Stock Forecast is based on your current time horizon. Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. PLX's current price target is $ Learn why top analysts are making this stock forecast for Protalix BioTherapeutics at MarketBeat. (NYSEMKT: PLX) Protalix Biotherapeutics stock price per share is $ today (as of Aug 23, ). What is Protalix Biotherapeutics's Market Cap. Analyst Price Targets ; ; Average ; Current ; High. View Protalix Biotherapeutics, Inc. PLX stock quote prices, financial information, real-time forecasts, and company news from CNN. Protalix BioTherapeutics Stock Forecast, PLX stock price prediction. Price target in 14 days: USD. The best long-term & short-term Protalix. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since it has more than doubled. The current price of PLX is USD — it has increased by % in the past 24 hours. Watch Protalix BioTherapeutics, Inc. (DE) stock price performance more. Earnings for Protalix BioTherapeutics are expected to grow by % in the coming year, from $ to $ per share. Price to Earnings Ratio vs. the Market.
Get Protalix Biotherapeutics Inc (PLX:NYSE American) real-time stock quotes, news, price and financial information from CNBC. Find the latest Protalix BioTherapeutics, Inc. (PLX) stock quote, history, news and other vital information to help you with your stock trading and. The average one-year price target for Protalix BioTherapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. Get a real-time Protalix BioTherapeutics, Inc. (PLX) stock price quote with breaking news, financials, statistics, charts and more. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ PLX will report FY earnings on 03/13/ Yearly Estimates. Get the latest Protalix Biotherapeutics (PLX) stock forecast for tomorrow and next week. Stay ahead of the game with our Protalix Biotherapeutics stock. PLX Stock Overview · Earnings are forecast to grow % per year · Trading at good value compared to peers and industry · Shareholders have been diluted in the. (DE) future price: according to them, PLX price has a max estimate of USD and a min estimate of USD. Watch PLX chart and read a more detailed. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. PLX will report earnings.
Looking to buy Protalix Biotherapeutics Stock? View today's PLX stock price, trade commission-free, and discuss PLX stock updates with the investor. Protalix Biotherapeutics reported an EPS of -$ in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went. Get the latest updates on Protalix BioTherapeutics, Inc. (DE) Common Stock (PLX) after hours trades, after hours share volumes, and more. Protalix BioTherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PLX updated stock price target summary. PLX is expected to report earnings to fall % to -1 cents per share on August 12 Est. Est. Est. The last earnings report on May 10 showed earnings.
PLXP - PLx Pharma - Stock Forecast PLXP is currently covered by 3 analysts with an average price target of $ This is a potential upside of $ (0%). Discover all the factors affecting Protalix Biotherapeutics's share price. PLX is currently rated as a Value Trap | Stockopedia. AI Munafa prediction value: 10 as on Fri · How is AI Munafa prediction value determined? · Stock price target for Protalix Biotherapeutics PLX are. See VIET NAM NATIONAL PETROLEUM GROUP stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better. Protalix Biotherapeutics Inc News & Analysis · Earnings call: Protalix reports progress on PRX and stable finances · PLX stock touches week low at $
How To Open A Gas Station Franchise | How To Get Off Parole Early